Related Experiment Video
Updated: Nov 16, 2025
09:14
An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay
Published on: January 26, 2019
11.2K
Strategies for active and passive pediatric RSV immunization
Katherine M Eichinger1, Jessica L Kosanovich2, Madeline Lipp3
1Department of Pharmacy and Therapeutics, University of Pittsburgh School of Pharmacy, and Clinical and Translational Science Institute, University of Pittsburgh, Pittsburgh, PA, USA.
Therapeutic Advances in Vaccines and Immunotherapy
|February 24, 2021
Summary
Developing a pediatric respiratory syncytial virus (RSV) vaccine is challenging due to infant immune responses and maternal antibodies. This review explores age-specific immunity to inform future RSV vaccine strategies for infants.
Area of Science:
- Pediatric immunology
- Vaccinology
- Virology
Background:
- Respiratory syncytial virus (RSV) is a major cause of severe lower respiratory tract infections in infants.
- Despite extensive research, licensed RSV vaccines for children remain unavailable.
- Infant immune responses, including maternal antibody interference and a Th2 bias, complicate vaccine development.
Purpose of the Study:
- To provide an age-specific understanding of RSV immunity in infants.
- To review historical and future strategies for preventing infant RSV infections.
- To guide the development of effective pediatric RSV vaccines.
Main Methods:
- Review of historical and current research on RSV pathogenesis and immunology.
- Analysis of challenges in pediatric RSV vaccine development.
- Evaluation of passive and active immunization strategies for infants.
Main Results:
- Infant immune systems present unique challenges for vaccine efficacy.
- Maternal antibodies can interfere with active infant immunization.
- Novel adjuvants and antigen formulations are being explored to modulate immune responses.
Conclusions:
- An age-specific understanding of infant immunity is crucial for successful pediatric RSV vaccine design.
- Strategies like maternal immunization and infant vaccination with pre-fusion F protein antigens and novel adjuvants show promise.
- Avoiding Th2 immune polarization is key for effective RSV vaccine responses in infants.
Related Concept Videos
01:31Active versus Passive Immunity
9.3K
Immunity, along with the ability to limit pathogen growth to prevent significant body tissue damage, can be gained either by (1) actively developing an immune response within the individual after exposure to a pathogen or after getting vaccinated or (2) passively transferring immune components from an immune individual to one who is nonimmune. Both these forms of immunity can be found naturally and in medical practices.
Active Immunity
Active immunity refers to the resistance one develops...
Active Immunity
Active immunity refers to the resistance one develops...
9.3K
01:51Vaccinations
49.2K
Overview
49.2K
01:30Pneumonia V: Nursing management and Prevention
2.9K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
2.9K
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
102
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
102
01:28Pneumonia IV: Management
573
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
573
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
100
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
100